Delivery Order SPE2DB22D1106-SPE2DB24FFAG3

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $6,251.40 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565066471 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,019.20 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for 4,565 units of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corporation's Corporate Office Division a $4,059.42 Firm Fixed Price delivery order contract to supply 4,564,802,345 units of the pharmaceutical drug TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,483.36 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,451.40 firm-fixed-price delivery order (SPE2DB22D2005 | SPE2DB24FJMA1) to Amerisourcebergen Drug Corp's Corporate Office division for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the U.S....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $19,808.77 to AmerisourceBergen Drug Corp for the supply of 4,566,598,880 units of the TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,169,765 units of the pharmaceutical drug TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,452.75, has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, worth $3,483.36, for the supply of 4565110247 TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,161.12 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564891985 - TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a $4,517.41 firm-fixed-price delivery order (SPE2DB22D3301) to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4565110108 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DB24FZ0FH) with DLA Troop Support Medical to provide a wide range of pharmaceutical and medical supplies to support Department of Defense healthcare requirements...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFAG3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $7,547.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,565,063,616 units of the pharmaceutical drug TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceuticals and medical supplies to the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain capabilities to efficiently meet the government's critical medical product needs.

Generated 10/2/24, 11:18 AM